Axoft
Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders
$55MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders
Develops interventional therapies for pulmonary hypertension and heart failure